Interaction of cytochrome P450 3A4 with cannabinoids and the drug darifenacin
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Irina F Sevrioukova. Beteiligte Einrichtung: Department of Molecular Biology and Biochemistry, University of California, Irvine, California, USA. Electronic address: sevrioui@uci.edu. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Dronabinol, Cannabinoids, Benzofurans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, Office of Science.
Abstract (Originalsprache)
Cytochrome P450 3A4 (CYP3A4) is an important drug-metabolizing enzyme whose substrate binding mechanism remains incompletely understood because of insufficient structural information. This study investigated how CYP3A4 interacts with cannabinoids, (-)-trans-Δ9-tetrahydrocannabinol (THC), cannabidiol and cannabinol, and a muscarinic receptor blocker, darifenacin, using spectral, mutagenesis, and structural approaches. It was found that THC and cannabidiol act as type I ligands and induce a nearly complete high-spin transition in CYP3A4 (Kd of 1.9 μM and 3.6 μM, respectively), whereas cannabinol causes only negligible spectral changes. In the crystal structure, THC approaches the heme with the cyclohexenyl C7 and C8 atoms, the main sites of metabolism, without triggering any significant structural perturbations. Darifenacin is also a type I ligand but has two binding sites (Kd of 11 μM and 712 μM) and associates to the high-affinity site in the crystal structure, where it adopts an arched conformation, placing the dihydrobenzofuran moiety above the heme suitably for the ring opening and C7 hydroxylation, the main routes of metabolism. Polar interactions with S119 and R212 facilitate but are not essential for the THC binding, likely driven by hydrophobic interactions and steric complementarity with the active site. In contrast, H-bonding to S119 is critical for the complex formation with darifenacin. The new X-ray models have expanded the structural library of productive complexes of CYP3A4 and helped identify a mechanism through which local changes in the active site could transmit to the remote areas to further optimize substrate binding and promote metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Biochemistry, University of California, Irvine, California, USA. Electronic address: sevrioui@uci.edu.
Förderung
- NIEHS NIH HHS
- NIGMS NIH HHS
- Office of Science
- National Institute of Environmental Health Sciences
- Basic Energy Sciences
- Biological and Environmental Research
- National Institutes of Health
- U.S. Department of Energy
Zitieren
APA
Sevrioukova, I. F. (2025). Interaction of cytochrome P450 3A4 with cannabinoids and the drug darifenacin. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110709
Vancouver
Sevrioukova IF. Interaction of cytochrome P450 3A4 with cannabinoids and the drug darifenacin. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110709
BibTeX
@article{Sevrioukova2025,
author = {Sevrioukova, Irina F},
title = {Interaction of cytochrome P450 3A4 with cannabinoids and the drug darifenacin},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110709}
}
EUVIMED